Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress on immunotherapy in triple‑negative breast cancer (Review)
Xiaoxiao Zhang, Xueying Ge, Tinghan Jiang, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 2
Open Access | Times Cited: 19

Showing 19 citing articles:

Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
Yaru Wang, Yue Sun, Feiran Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115866-115866
Open Access | Times Cited: 14
Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling
Zhaohui Zhu, Hanlu Wang, Qian Xu, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 4, pp. e244-e257.e1
Closed Access | Times Cited: 4
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles
Wen Zhang, Yi­hui Zhai, Ying Cai, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3218-3231
Open Access | Times Cited: 3
Endoplasmic reticulum-targeted NIR-II phototherapy combined with inflammatory vascular suppression elicits a synergistic effect against TNBC
Guoyun Wan, Xuheng Chen, Jiayu Chen, et al.
Biomaterials Science (2023) Vol. 11, Iss. 5, pp. 1876-1894
Closed Access | Times Cited: 8
Mechanism of action of resveratrol affecting the biological function of breast cancer through the glycolytic pathway
Yu Gao, Yaoyao Wang, Baodi Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters
Olga Stanowska, Olga Kuczkiewicz‐Siemion, Małgorzata Dębowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5524-5524
Open Access | Times Cited: 8
An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer.
Xuyu Cheng, Yuan Liang, Hongfei Zhang, et al.
PubMed (2023) Vol. 15, Iss. 4, pp. 2598-2609
Closed Access | Times Cited: 4
Efficacy and Safety of Atezolizumab Monotherapy or Combined Therapy with Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Mina Alimohammadi, Fatemeh Faramarzi, Alireza Mafi, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 31, pp. 2461-2476
Closed Access | Times Cited: 4
Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer
Lea Ling‐Yu Kan, Ben Chung-Lap Chan, Ping‐Chung Leung, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5804-5804
Open Access | Times Cited: 3
Unleashing Breast Cancer Progression: miR-455-5p's Targeting of SOCS3 Drives Proliferation, Migration, and Invasion
Xin Li, Bing Peng, Jian Li, et al.
Protein and Peptide Letters (2023) Vol. 30, Iss. 12, pp. 992-1000
Closed Access | Times Cited: 1
[A recombinant adeno-associated virus expressing secretory TGF-β type Ⅱ receptor inhibits triple-negative murine breast cancer 4T1 cell proliferation and lung metastasis in mice].
Zhi Cui, Chuang Ma, Q. Wang, et al.
PubMed (2024) Vol. 44, Iss. 5, pp. 818-826
Closed Access
JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway
Jianjie Li, Xiangmei Zhang, Xueliang Liu, et al.
Expert Review of Anticancer Therapy (2024), pp. 1-12
Closed Access
Pregnancy-associated triple-negative breast cancer: A case report and literature review
Weichao Bao, Xiaolin Ma, Yuan Xue, et al.
Medicine (2024) Vol. 103, Iss. 41, pp. e40059-e40059
Open Access
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The Mechanism of T Cells in the Microenvironment of Triple Negative Breast Cancer and the Application Potential of Immunotherapy
Jiayue Qiao, Furong Wu
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 7, pp. 677-685
Closed Access
Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer
Zhun Yu, Qi He, Guoping Xu
Translational Cancer Research (2022) Vol. 11, Iss. 12, pp. 4303-4314
Open Access | Times Cited: 1
AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
Jing Chen, Bing Tan, Wei Zhuang, et al.
Clinical and Experimental Obstetrics & Gynecology (2023) Vol. 50, Iss. 8
Open Access
Comparison of immunotherapy with chemotherapy on triple-negative breast cancer
Rui‐Ting Zhou
(2023), pp. 106-106
Closed Access
Page 1

Scroll to top